Fly News Breaks for January 10, 2020
Jan 10, 2020 | 11:32 EDT
Wells Fargo analyst Larry Biegelsen noted that the USPTO's Patent Trial and Appeal Board declined to institute an Inter Partes Review of Abbot's (ABT) '366 patent yesterday, but he believes this decision "is of zero importance" to the bigger fight between the company and Edwards (EW). Abbott alleges that Edwards' PASCAL device infringes several Abbott patents, but the case against Edwards is built on five other patents, not including '366, explained the analyst. Biegelsen noted that the PASCAL case is set for trial in May of this year and he expects news on several other IPR petitions between now and then.
News For ABT;EW From the Last 2 Days
Feb 26, 2021 | 09:21 EST
Medical Supplies & Devices Analyst Marcus holds a conference call with CEO Mussallem on February 26 at 11 am hosted by JPMorgan.